Characterization of MRC1/CD206 glycosylation in macrophages
Closed Solicitation Posted
- Solicitation number
- 75N95C24P00094
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Athens, Georgia 30602, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
Paragraph 1:
The National Institutes of Health (NIH), through the National Center for Advancing Translational Sciences (NCATS), intends to award a non-competitive contract to the University of Georgia Research Foundation, Inc. for the characterization of the glycosylation profile of the MRC1/CD206 receptor in macrophages. The purpose of this project is to develop a more nuanced understanding of the receptor glycosylation to support the modulation of the immune system and the development of new therapeutic treatments. The procurement is classified under NAICS code 541990 with a size standard of $25,000,000, and the acquisition is conducted under the simplified acquisition procedures of FAR Part 13. Responses to this notice must be submitted by email to Rhanda Lopez at rhanda.lopez@nih.gov no later than September 16, 2024 at 5:30pm Eastern Standard Time.
Paragraph 2:
This procurement is not set-aside, and the intended awardee is the University of Georgia Research Foundation, Inc. No additional details on potential award values or budget ranges are provided. The place of performance is Athens, GA 30602, USA.
Notice text
PRE-SOLICITATION NOTICE OF INTENT
NON-COMPETITIVE
INTRODUCTION
PURSUANT TO FAR Subpart 5.2—Synopses of Proposed Contract Actions, THIS IS A PRE-SOLICITATION NOTICE OF A PROPOSED CONTRACT ACTION.
THIS IS A PRE-SOLICITATION NON-COMPETITIVE NOTICE OF INTENT TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Center for Advancing Translational Sciences (NCATS), a center of the National Institutes of Health, intends to negotiate and award a contract without providing for full and open competition (including brand name) to University of Georgia Research Foundation, Inc., 310 E Campus Rd. Rm 409, Athens, GA 30602-1589 for Characterization of MRC1/CD206 glycosylation in macrophages.
NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE
The intended procurement is classified under NAICS code 541990 with a Size Standard of $25,000,000.
REGULATORY AUTHORITY
The resultant contract will include all applicable provisions and clauses of the Federal Acquisition Requlation (FAR) in effect through the Federal Acquisition Circular (FAC) 2023-01 dated 12/30/2022.
STATUTORY AUTHORITY
This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), Soliciting from a single source.
DESCRIPTION OF REQUIREMENT
Purchase Description
Characterization of MRC1/CD206 glycosylation in macrophages. The purpose of this project is to characterize the glycosylation profile of CD206 using mass spectrometry-based glycoproteomics approach.
Purpose and Objectives
Included in this process is the development of new and promising therapeutics for the potential modulation of the immune system. NCATS is characterizing small molecule modulators of CD206 and requires a more nuanced understanding of the receptor glycosylation.
CLOSING STATEMENT
This synopsis is not a request for competitive proposals. However, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.
Respondents that believe that they are manufacturers or authorized resellers of the brand-name product specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; quantity; estimated price or cost; shipping, handling, and/or installation charges; and delivery date after receipt of order.
In addition the Unique Entity Identifier (UEI) issued by the System for Awards Management (SAM.gov), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.
Responses must be submitted by email to Rhanda Lopez at rhanda.lopez@nih.gov no later than September 16, 2024 at 5:30pm Eastern Standard Time and must reference solicitation number 75N95C24P00094.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Stability Testing for ManNAc Drug Product produced in Campaigns 5 and 6. Stability testing will occur under regulatory compliance | Office of Logisitics and Acquisition Operations | No set-aside | |
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity